000 | 02674 a2200637 4500 | ||
---|---|---|---|
005 | 20250513185633.0 | ||
264 | 0 | _c19990921 | |
008 | 199909s 0 0 eng d | ||
022 | _a0888-8809 | ||
024 | 7 |
_a10.1210/mend.13.7.0293 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeternes, O M | |
245 | 0 | 0 |
_aA dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells. _h[electronic resource] |
260 |
_bMolecular endocrinology (Baltimore, Md.) _cJul 1999 |
||
300 |
_a1071-83 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a3T3 Cells _xdrug effects |
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xdrug effects |
650 | 0 | 4 | _aCell Cycle Proteins |
650 | 0 | 4 |
_aColforsin _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xdrug effects |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xdrug effects |
650 | 0 | 4 | _aDNA-Binding Proteins |
650 | 0 | 4 | _aDual Specificity Phosphatase 1 |
650 | 0 | 4 | _aDual Specificity Phosphatase 6 |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aFlavonoids _xpharmacology |
650 | 0 | 4 |
_aImmediate-Early Proteins _xdrug effects |
650 | 0 | 4 | _aMAP Kinase Kinase Kinase 1 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMitogen-Activated Protein Kinase 1 |
650 | 0 | 4 | _aMitogen-Activated Protein Kinase 3 |
650 | 0 | 4 | _aMitogen-Activated Protein Kinases |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aPhosphoprotein Phosphatases |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xmetabolism |
650 | 0 | 4 |
_aProtein Kinase C _xdrug effects |
650 | 0 | 4 | _aProtein Phosphatase 1 |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-raf _xmetabolism |
650 | 0 | 4 |
_aSerine _xmetabolism |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xmetabolism |
650 | 0 | 4 | _aTranscription Factors |
650 | 0 | 4 | _aTranscriptional Activation |
650 | 0 | 4 | _aets-Domain Protein Elk-1 |
700 | 1 | _aJohansen, B | |
700 | 1 | _aMoens, U | |
773 | 0 |
_tMolecular endocrinology (Baltimore, Md.) _gvol. 13 _gno. 7 _gp. 1071-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/mend.13.7.0293 _zAvailable from publisher's website |
999 |
_c10364611 _d10364611 |